company

PHARMACOMP Bror-Lennart Mentzoni

3217 SANDEFJORD

Return on Equity
257,89 %
Current Ratio
129,82
Debt-to-Equity Ratio
0
Key figures (NOK)2004
Revenue8 934 000
Net Income7 987 000
Total Assets3 120 000
Total Equity3 097 000
Income (NOK)2004
Revenue8 934 000
Expenditure9 011 000
Operating Profit7 924 000
Financial Income64 000
Financial Costs0
Financial Balance64 000
Earnings Before Tax7 987 000
Tax0
Net Income7 987 000
Balance (NOK)2004
Total Fixed Assets264 000
Total Current Assets2 856 000
Total Assets3 120 000
Total Retained Equity3 097 000
Total Equity3 097 000
Total Long-Term Debt0
Total Current Debt22 000
Total Equity and Debt3 120 000
Cash flow (NOK)2004
Sales Income8 934 000
Other Income0
Revenue8 934 000
Cost of Goods Sold6 895 000
Salary Costs1 295 000
Depreciation208 000
Impairment0
Expenditure9 011 000
Operating Profit7 924 000
Financial Income64 000
Financial Costs0
Financial Balance64 000
Dividends0
Net Income7 987 000
Balance details (NOK)2004
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets264 000
Total Fixed Assets264 000
Stock0
Total Investments2 856 000
Cash, Bank0
Total Current Assets2 856 000
Total Assets3 120 000
Total Equity3 097 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes22 000
Dividends0
Other Current Debt0
Total Current Debt22 000
Total Equity and Debt3 120 000
Financial indicators2004
Return on Equity257,89 %
Debt-to-Equity Ratio0
Operating Profit Margin88,69 %
Current Ratio129,82
Quick Ratio129,82
Equity Ratio0,99
Gross Profit Margin22,82 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English